These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 20864734)

  • 1. Novel approach for characterizing ubiquitin E3 ligase function.
    Marblestone JG; Suresh Kumar KG; Eddins MJ; Leach CA; Sterner DE; Mattern MR; Nicholson B
    J Biomol Screen; 2010 Dec; 15(10):1220-8. PubMed ID: 20864734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Screening of HECT E3 Ubiquitin Ligases Using UbFluor.
    Foote PK; Krist DT; Statsyuk AV
    Curr Protoc Chem Biol; 2017 Sep; 9(3):174-195. PubMed ID: 28910856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteins.
    Marblestone JG; Larocque JP; Mattern MR; Leach CA
    Biochim Biophys Acta; 2012 Nov; 1823(11):2094-7. PubMed ID: 22721718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Generic Platform for Cellular Screening Against Ubiquitin Ligases.
    Maculins T; Carter N; Dorval T; Hudson K; Nissink JW; Hay RT; Alwan H
    Sci Rep; 2016 Jan; 6():18940. PubMed ID: 26743172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases.
    Tian M; Zeng T; Liu M; Han S; Lin H; Lin Q; Li L; Jiang T; Li G; Lin H; Zhang T; Kang Q; Deng X; Wang HR
    J Biol Chem; 2019 Feb; 294(8):2880-2891. PubMed ID: 30587574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway.
    De Cesare V; Johnson C; Barlow V; Hastie J; Knebel A; Trost M
    Cell Chem Biol; 2018 Sep; 25(9):1117-1127.e4. PubMed ID: 30017913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orchestra for assembly and fate of polyubiquitin chains.
    Kuhlbrodt K; Mouysset J; Hoppe T
    Essays Biochem; 2005; 41():1-14. PubMed ID: 16250894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of approaches for screening for ubiquitin ligase inhibitors.
    Sun Y
    Methods Enzymol; 2005; 399():654-63. PubMed ID: 16338387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening for inhibitors of the e3 ubiquitin ligase APC.
    Huang J; Sheung J; Dong G; Coquilla C; Daniel-Issakani S; Payan DG
    Methods Enzymol; 2005; 399():740-54. PubMed ID: 16338393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel E3 ubiquitin ligases that regulate histone protein levels in the budding yeast Saccharomyces cerevisiae.
    Singh RK; Gonzalez M; Kabbaj MH; Gunjan A
    PLoS One; 2012; 7(5):e36295. PubMed ID: 22570702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarrays.
    Andrews PS; Schneider S; Yang E; Michaels M; Chen H; Tang J; Emkey R
    Assay Drug Dev Technol; 2010 Aug; 8(4):471-87. PubMed ID: 20804422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A High-Throughput Screening Strategy for Development of RNF8-Ubc13 Protein-Protein Interaction Inhibitors.
    Weber E; Rothenaigner I; Brandner S; Hadian K; Schorpp K
    SLAS Discov; 2017 Mar; 22(3):316-323. PubMed ID: 27909234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of E2-RING Interactions in Governing RNF4-Mediated Substrate Ubiquitination.
    DiBello A; Datta AB; Zhang X; Wolberger C
    J Mol Biol; 2016 Nov; 428(23):4639-4650. PubMed ID: 27678051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of SUMO-dependent ubiquitylation in vitro.
    Keusekotten K; Praefcke GJ
    Methods Mol Biol; 2012; 832():111-23. PubMed ID: 22350879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all.
    Hoppe T
    Trends Biochem Sci; 2005 Apr; 30(4):183-7. PubMed ID: 15817394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Ubiquitination Platform Identifies Methyl Ellipticiniums as Ubiquitin Ligase Inhibitors.
    Wilson BAP; Voeller D; Smith EA; Wamiru A; Goncharova EI; Liu G; Lipkowitz S; O'Keefe BR
    SLAS Discov; 2021 Aug; 26(7):870-884. PubMed ID: 33882749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme reversal to explore the function of yeast E3 ubiquitin-ligases.
    MacDonald C; Winistorfer S; Pope RM; Wright ME; Piper RC
    Traffic; 2017 Jul; 18(7):465-484. PubMed ID: 28382714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1.
    Eisele F; Wolf DH
    FEBS Lett; 2008 Dec; 582(30):4143-6. PubMed ID: 19041308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3-ubiquitin ligases and recent progress in osteoimmunology.
    Asano Y; Matsumoto Y; Wada J; Rottapel R
    Front Immunol; 2023; 14():1120710. PubMed ID: 36911671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.